D'Jaen, Gabriela A <br/><br/>
Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration.  [electronic resource] 

 -  Clinical lung cancer  Nov 2010 
 - 396-404 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1938-0690 
<br/><br/><label>Standard No.: </label>10.3816/CLC.2010.n.051  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--epidemiology<br/>Adolescent<br/>Adult<br/>Age Factors<br/>Age of Onset<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--adverse effects<br/>Antiretroviral Therapy, Highly Active--methods<br/>CD4 Lymphocyte Count<br/>Carcinoma, Squamous Cell--epidemiology<br/>Child<br/>Databases, Factual<br/>Female<br/>HIV Infections--complications<br/>Humans<br/>International Cooperation<br/>Lung Neoplasms--epidemiology<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>SEER Program--statistics & numerical data<br/>Survival<br/>Treatment Outcome<br/>Young Adult